ArticleTherapeutic advances in gastroenterology2019

Cabozantinib for patients with advanced hepatocellular carcinoma: a cost-effectiveness analysis.

Amir Shlomai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.